R&D expert shares secrets to fume hood safety in the lab
Learn how far the humble chemical fume hood has come and why flexible, modern research laboratories should not be without the latest ductless filtration equipment
Learn how far the humble chemical fume hood has come and why flexible, modern research laboratories should not be without the latest ductless filtration equipment
Watch this webinar to discover how scientists at the Cedars Sinai Advanced Clinical Biosystems Research Institute are streamlining the processing of plasma metabolites
Dr. Chris Vakulskas talks about the work he is doing with CRISPR, the challenges involved and new innovations within the field
Novel cyclic IMS and new SYNAPT XS lead Waters’ portfolio of solutions that promise unlimited experimental opportunities and analytical flexibility
Discover the game-changing advancements and key discussions driving lab automation forward
Catch up on the latest lab automation hot topics and new technology from SLAS2023
From tackling post-pandemic changes in the biopharmaceutical supply chain to addressing unmet therapeutic needs, simplified off-target effect analysis, and more, explore the latest advances in drug discovery with these free resources
The Jackson Laboratory explores the efficacy of humanized mice as an alternative to non-human primates in drug development studies
The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly
How advanced imaging technology is progressing drug discovery through understanding of GPCR-dependent second-messenger systems
On World AIDS Day, SelectScience looks at advances in HIV diagnostic testing and monitoring
Agreement adds commercial firepower for QIAGEN’s U.S. launch of the next-generation platform for syndromic insights initially for respiratory conditions
A new network in the US – the Readiness Acceleration and Innovation Network, or RAIN for short – is catalyzing biotech business and training the next generation of young scientists to work in a laboratory setting. As ever, equipment is key
In this editorial feature, we bring you the latest developments in gene editing and CRISPR technology
Dr. Megan Allyse from the Mayo Clinic Center for Individualized Medicine explains why gene editing is not yet suitable for medical practice
QIAGEN’s GeneReader NGS System Gains Further Validation in Oncology Research Applications with New Independent Performance Review Data
Kerafast's innovative scheme offers access to hundreds of reagents
Hear how David Foley, Principal Scientist at Pfizer, uses reaction monitoring NMR spectroscopy